Comparison of cell culture-grown JC virus (primary human fetal glial cells and the JCI cell line) and recombinant JCV VP1 as antigen for the detection of anti-JCV antibody by haemagglutination inhibition

Journal of Virological Methods

Volumn 109, Issue 1, 2003, Pages 47-54

  Knowles, W A ^a   Sasnauskas, K ^b  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^b VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Anti JCV antibody; Haemagglutination inhibition; JCI cell line; JCV antigen; Primary human fetal glial cells; Yeast expressed recombinant JCV VP1

Indexed keywords

JC VIRUS ANTIGEN; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CELL CULTURE; CELL LINE; CELL LYSATE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FETUS CELL; GLIA CELL; HEMAGGLUTINATION INHIBITION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; JC VIRUS; MALE; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RELIABILITY; VIROGENESIS; VIRUS CULTURE; VIRUS DETECTION;

JC VIRUS;

EID: 0037378405     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(03)00043-0     Document Type: Article

References (59)

1. Akatani K., Imai M., Kimura M., Nagashima K., Ikegami N. Propagation of JC virus in human neuroblastoma cell line IMR-32. J. Med. Virol. 43:1994;13-19.
2. Assouline J.G., Major E.O. Human fetal Schwann cells support JC virus multiplication. J. Virol. 65:1991;1002-1006.
3. Atwood W.J., Amemiya K., Traub R., Harms J., Major E.O. Interaction of the human polyomavirus, JCV, with human B-lymphocytes. Virology. 190:1992;716-723.
4. Beckmann A.M., Shah K.V. Propagation and primary isolation of JCV and BKV in urinary epithelial cell cultures. Sever J.L., Madden D.L. Polyomaviruses and Human Neurological Diseases. Progress in Clinical and Biological Research. 105:1983;3-14 Liss, New York.
5. Berger J.R., Concha M. Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J. Neurovirol. 1:1995;5-18.
6. Brouqui P., Bollet C., Delmont J., Bourgeade A. Diagnosis of progressive multifocal leucoencephalopathy by PCR detection of JC virus from CSF. Lancet. 339:1992;1182.
7. Chang D., Fung C.-Y., Ou W.-C., Chao P.-C., Li S.-Y., Wang M., Huang Y.-L., Tzeng T.-Y., Tsai R.-T. Self-assembly of the JC virus major capsid protein, VP1, expressed in insect cells. J. Gen. Virol. 78:1997;1435-1439.
8. Chang D., Liou Z.-M., Ou W.-C., Wang K.-Z., Wang M., Fung C.-Y., Tsai R.-T. Production of the antigen and the antibody of the JC virus major capsid protein VP1. J. Virol. Methods. 59:1996;177-187.
9. Cinque P., Scarpellini P., Vago L., Linde A., Lazzarin A. Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS. 11:1997;1-17.
10. Coleman D.V., Wolfendale M.R., Daniel R.A., Dhanjal N.K., Gardner S.D., Gibson P.E., Field A.M. A prospective study of human polyomavirus infection in pregnancy. J. Infect. Dis. 142:1980;1-8.
11. Daniel A.M., Swenson J.J., Mayreddy R.P.R., Khalili K., Frisque R.J. Sequences within the early and late promoters of archetype JC virus restrict viral DNA replication and infectivity. Virology. 216:1996;90-101.
12. Daniel R., Shah K., Madden D., Stagno S. Serological investigation of the possibility of congenital transmission of papovavirus JC. Infect. Immun. 33:1981;319-321.
13. De Luca A., Cingolani A., Linzalone A., Ammassari A., Murri R., Giancola M.L., Maiuro G., Antinori A. Improved detection of JC virus DNA in cerebrospinal fluid for diagnosis of AIDS-related progressive multifocal leukoencephalopathy. J. Clin. Microbiol. 34:1996;1343-1346.
14. Feigenbaum L., Khalili K., Major E., Khoury G. Regulation of the host range of human papovavirus JCV. Proc. Natl. Acad. Sci. 84:1987;3695-3698.
15. Ferrante P., Caldarelli-Stefano R., Omodeo-Zorini E., Cagni A.E., Cocchi L., Suter F., Maserati R. Comprehensive investigation of the presence of JC virus in AIDS patients with and without progressive multifocal leukoencephalopathy. J. Med. Virol. 52:1997;235-242.
16. Fong I.W., Britton C.B., Luinstra K.E., Toma E., Mahony J.B. Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J. Clin. Microbiol. 33:1995;484-486.
17. Frye S., Trebst C., Dittmer U., Petry H., Bodemer M., Hunsmann G., Weber T., Lüke W. Efficient production of JC virus in SVG cells and the use of purified viral antigens for analysis of specific humoral and cellular immune response. J. Virol. Methods. 63:1997;81-92.
18. Gardner S.D., Mackenzie E.F.D., Smith C., Porter A.A. Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. J. Clin. Pathol. 37:1984;578-586.
19. Gibson P.E., Knowles W.A., Hand J.F., Brown D.W.G. Detection of JC virus DNA in the cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J. Med. Virol. 39:1993;278-281.
20. Giudici B., Vaz B., Bossolasco S., Casari S., Brambilla A.M., Lüke W., Lazzarin A., Weber T., Cinque P. Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin. Infect. Dis. 30:2000;95-99.
21. Guillaume B., Sindic C.J., Weber T. Progressive multifocal leukoencephalopathy: simultaneous detection of JCV DNA and anti-JCV antibodies in the cerebrospinal fluid. Eur. J. Neurol. 7:2000;101-106.
22. Hale A.D., Bartkevičiute D., Dargevičiute A., Jin L., Knowles W., Staniulis J., Brown D.W.G., Sasnauskas K. Expression and antigenic characterization of the major capsid proteins of human polyomaviruses BK and JC in Saccharomyces cerevisiae. J. Virol. Methods. 104:2002;93-98.
23. Hamilton R.S., Gravell M., Major E.O. Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus. J. Clin. Microbiol. 38:2000;105-109.
24. Hara K., Sugimoto C., Kitamura T., Aoki N., Taguchi F., Yogo Y. Archetype JC virus efficiently replicates in COS-7 cells, simian cells constitutively expressing simian virus 40 T antigen. J. Virol. 72:1998;5335-5342.
25. Heimer G.V., Taylor C.E.D. Improved mountant for immunofluorescence preparations. J. Clin. Pathol. 27:1974;254-256.
26. Henson J., Rosenblum M., Armstrong D., Furneaux H. Amplification of JC virus DNA from brain and cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. Neurology. 41:1991;1967-1971.
27. Hogan T.F., Borden E.C., McBain J.A., Padgett B.L., Walker D.L. Human polyomavirus infections with JC virus and BK virus in renal transplant patients. Ann. Intern. Med. 92:1980;373-378.
28. Knowles W.A. The modern diagnosis of progressive multifocal leucoencephalopathy (PML). PHLS Microbiol. Dig. 12:1995;145-149.
29. Knowles W.A., Gibson P.E., Gardner S.D. Serological typing scheme for BK-like isolates of human polyomavirus. J. Med. Virol. 28:1989;118-123.
30. Knowles W.A., Gibson P.E., Hand J.F., Brown D.W.G. An M-antibody capture radioimmunoassay (MACRIA) for detection of JC virus-specific IgM. J. Virol. Methods. 40:1992;95-106.
31. Knowles W.A., Luxton R.W., Hand J.F., Gardner S.D., Brown D.W.G. The JC virus antibody response in serum and cerebrospinal fluid in progressive multifocal leucoencephalopathy. Clin. Diag. Virol. 4:1995;183-194.
32. Knowles W.A., Pillay D., Johnson M.A., Hand J.F., Brown D.W.G. Prevalence of long-term BK and JC excretion in HIV-infected adults and lack of correlation with serological markers. J. Med. Virol. 59:1999;474-479.
33. Knowles W.A., Sharp I.R., Efstratiou L., Hand J.F., Gardner S.D. Preparation of monoclonal antibodies to JC virus and their use in the diagnosis of progressive multifocal leucoencephalopathy. J. Med. Virol. 34:1991;127-131.
34. Lynch K.J., Frisque R.J. Factors contributing to the restricted DNA replicating activity of JC virus. Virology. 180:1991;306-317.
35. Major E.O., Miller A.E., Mourrain P., Traub R.G., deWidt E., Sever J. Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc. Natl. Acad. Sci. 82:1985;1257-1261.
36. Mandl C., Walker D.L., Frisque R.J. Derivation and characterization of POJ cells, transformed human fetal glial cells that retain their permissivity for JC virus. J. Virol. 61:1987;755-763.
37. Mäntyjärvi R.A., Arstila P.P., Meurman O.H. Hemagglutination by BK virus, a tentative new member of the papovavirus group. Infect. Immun. 6:1972;824-828.
38. Miyamura T., Furuno A., Yoshiike K. DNA rearrangement in the control region for early transcription in a human polyomavirus JC host range mutant capable of growing in human embryonic kidney cells. J. Virol. 54:1985;750-756.
39. Miyamura T., Yoshiike K., Takemoto K.K. Characterization of JC papovavirus adapted to growth in human embryonic kidney cells. J. Virol. 35:1980;498-504.
40. Monaco M.C.G., Atwood W.J., Gravell M., Tornatore C.S., Major E.O. JC virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency. J. Virol. 70:1996;7004-7012.
41. Nukuzuma S., Yogo Y., Guo J., Nukuzuma C., Itoh S., Shinohara T., Nagashima K. Establishment and characterization of a carrier cell culture producing high titres of polyoma JC virus. J. Med. Virol. 47:1995;370-377.
42. Ou W.-C., Wang M., Fung C.-Y., Tsai R.-T., Chao P.-C., Hseu T.-H., Chang D. The major capsid protein, VP1, of human JC virus expressed in Escherichia coli is able to self-assemble into a capsid-like particle and deliver exogenous DNA into human kidney cells. J. Gen. Virol. 80:1999;39-46.
43. Padgett B.L., Rogers C.M., Walker D.L. JC virus, a human polyomavirus associated with progressive multifocal leukoencephalopathy: additional biological characteristics and antigenic relationships. Infect. Immun. 15:1977;656-662.
44. Padgett B.L., Walker D.L. Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. J. Infect. Dis. 127:1973;467-470.
45. Padgett B.L., Walker D.L. Virologic and serologic studies of progressive multifocal leukoencephalopathy. Sever J.L., Madden D.L. Polyomaviruses and Human Neurological Diseases. Progress in Clinical and Biological Research. 105:1983;107-117 Liss, New York.
46. Padgett B.L., Walker D.L., ZuRhein G.M., Hodach A.E., Chou S.M. JC papovavirus in progressive multifocal leukoencephalopathy. J. Infect. Dis. 133:1976;686-690.
47. Raj G.V., Khalili K. Transcriptional regulation: lessons from the human neurotropic polyomavirus, JCV. Virology. 213:1995;283-291.
48. Sasnauskas K., Buzaite O., Vogel F., Jandrig B., Razanskas R., Staniulis J., Scherneck S., Krüger D.H., Ulrich R. Yeast cells allow high-level expression and formation of polyomavirus-like particles. Biol. Chem. 380:1999;381-386.
49. Sasnauskas, K., Hale, A.D., Jin, L., Knowles, W., Dargeviciute, A., Staniulis, J., Brown, D., 2001. Expression of the major capsid proteins of human polyomaviruses BK and JC in yeast. Abstracts of the EMBO Workshop 'The structural biology of small DNA tumor viruses', Siena, Italy, May 1-6, p. 6.
50. Shinohara T., Nagashima K., Major E.O. Propagation of the human polyomavirus, JCV, in human neuroblastoma cell lines. Virology. 228:1997;269-277.
51. Shishido Y., Nukuzuma S., Mukaigawa J., Morikawa S., Yasui K., Nagashima K. Assembly of JC virus-like particles in COS7 cells. J. Med. Virol. 51:1997;265-272.
52. Sindic C.J.M., Trebst C., Van Antwerpen M.P., Frye S., Enzensberger W., Hunsmann G., Lüke W., Weber T. Detection of CSF-specific oligoclonal antibodies to recombinant JC virus VP1 in patients with progressive multifocal leukoencephalopathy. J. Neuroimmunol. 76:1997;100-104.
53. Taguchi F., Kajioka J., Miyamura T. Prevalence rate and age of acquisition of antibodies against JC virus and BK virus in human sera. Microbiol. Immunol. 26:1982;1057-1064.
54. Takemoto K.K., Howley P.M., Miyamura T. JC human papovavirus replication in human amnion cells. J. Virol. 30:1979;384-389.
55. Telenti A., Marshall W.F., Aksamit A.J., Smilack J.D., Smith T.F. Detection of JC virus by polymerase chain reaction in cerebrospinal fluid from two patients with progressive multifocal leukoencephalopathy. Eur. J. Clin. Microbiol. Infect. Dis. 11:1992;253-254.
56. Wang M., Tzeng T.-Y., Fung C.-Y., Ou W.-C., Tsai R.-T., Lin C.-K., Tsay G.J., Chang D. Human anti-JC virus serum reacts with native but not denatured JC virus major capsid protein VP1. J. Virol. Methods. 78:1999;171-176.
57. Weber T., Trebst C., Frye S., Cinque P., Vago L., Sindic C.J.M., Schulz-Schaeffer W.J., Kretzschmar H.A., Enzensberger W., Hunsmann G., Lüke W. Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J. Infect. Dis. 176:1997;250-254.
58. Weber T., Turner R.W., Frye S., Ruf B., Haas J., Schielke E., Pohle H.-D., Lüke W., Lüer W., Felgenhauer K., Hunsmann G. Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction. J. Infect. Dis. 169:1994;1138-1141.
59. Yogo Y., Hara K., Guo J., Taguchi F., Nagashima K., Akatani K., Ikegami N. DNA-sequence rearrangement required for the adaptation of JC polyomavirus to growth in a human neuroblastoma cell line (IMR-32). Virology. 197:1993;793-795.